Sloan Kettering Secures Sanctions In Drug IP Case

By Shayna Posses (June 6, 2017, 3:17 PM EDT) -- A New York magistrate judge sanctioned a biopharmaceutical company and its counsel Monday for using protected information from its now-dismissed lawsuit against the Sloan Kettering Institute for Cancer Research over gene therapy patent rights to file suits in other courts, saying this behavior clearly violated a court order....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!